Publications by authors named "Monika Juzumaite"

Objectives: Violence and HIV/AIDS syndemic highly prevalent among women impairs HIV prevention efforts. Prolonged exposure to violence results in physical trauma and psychological distress. Building on previous findings regarding genital immune dysregulation following sexual abuse exposure, we investigate here whether systemic changes occur as well.

View Article and Find Full Text PDF
Article Synopsis
  • HIV/AIDS and sexual violence negatively impact women's health, but the link between sexual violence and increased HIV vulnerability is not well understood.
  • A study compared HIV-uninfected women who recently experienced sexual violence with those who hadn't, analyzing various biomarkers through blood and cervicovaginal fluid samples.
  • The results showed significant immune system changes in women exposed to sexual violence, indicating that these alterations could increase their susceptibility to HIV infection.
View Article and Find Full Text PDF

Sexual violence is associated with increased risk of HIV acquisition/transmission in women. Forced sex can result in physical trauma to the reproductive tract as well as severe psychological distress. However, immuno-biological mechanisms linking sexual violence and HIV susceptibility are incompletely understood.

View Article and Find Full Text PDF

Problem: Adolescent girls are disproportionately affected by the HIV/AIDS pandemic, accounting for 22% of all new HIV infections globally. Yet little is known regarding the immune microenvironment of the adolescent female reproductive tract, especially regarding differences among sexually active and inactive girls, a critical parameter to evaluate HIV susceptibility associated with young age and sexual debut.

Methods: Cervico-vaginal lavage (CVL) was collected from sexually active (10) and inactive (8) girls aged 11-19 years and analyzed by ELISA for inflammation-associated biomarkers IL-6, IL-8, TNF-α, MIP-3α, IL-1α, IL-1β, matrix metalloproteinases (MMP) 1, 2, 7, 8, and 9, as well as anti-HIV mediators, Elafin, SLPI, human beta-defensin 2, and tissue inhibitor of matrix metalloproteinases (TIMP) 1 and 2.

View Article and Find Full Text PDF

Botanical extracts of have been widely used for the treatment of upper respiratory infections. We sought to chemically examine fungal endophytes inhabiting , and to identify compounds produced by these endophytes with in vitro cytokine-suppressive activity. Twelve isolates from surface sterilized seeds of were subjected to fractionation and major components were isolated.

View Article and Find Full Text PDF

Echinacea preparations, which are used for the prevention and treatment of upper respiratory infections, account for 10% of the dietary supplement market in the U.S., with sales totaling more than $100 million annually.

View Article and Find Full Text PDF